Vaccine in front of the VRS for the elderly: In which autonomous communities will it put?
The Minister of Health of the Xunta, Antonio Gómez Caamañohas announced that Galicia will try to launch a new Clinical trial to evaluate the effectiveness of vaccination against Syncitial respiratory virus in older people.
Will do so in collaboration with the investigating group of the Sanitary Research Institute of Santiago de Compostela (IDIS)which leads Federico Martiñón. It has precisely took advantage of a visit to the IDIS facilities to make the ad. There she has been accompanied by the general director of Public Health, Carmen Durán, and the Health Area Manager, Ángel Facio, in addition to Luz Couce, the scientific director of IDIS, and Isabel Lista, director of the Foundation.
As explained Gómez Caamañothe Xunta de Galicia is waiting to present the project before the regulatory agencies and the ethical committee, organisms that must authorize it. THE CONSELLEIRO trust to obtain approval To be able to promote an essay aimed at reinforcing the protection of the health of Galician citizenship.
The regional head recalled that this visit is part of his commitment to approach the three Health Research Institutes of Galicia. In this regard, he stressed his own researcher status at IDIS and highlighted the scientific work of this center, which has More than 1,400 researchers and technicians. It has also referred to almost 50 million euros of financing captured last year for projects and More than 1,000 articles published scientists
Gómez Caamaño also pointed out that the regional administration seeks to strengthen its commitment to health research, “That was already reflected with the integration of the three institutes in the public sector and with the consolidation of the first places of research personnel as a statutory with the recent incorporation of 33 researchers”.
The Minister stressed that professionals and users of public health are the main beneficiaries of research in Galicia, citing projects that place the community “At the forefront” Like Cringenes, intended to detect more than 300 Rare diseases In neonates through a genetic screening.
He also recalled the collaboration between his department and the Group of Infectology, Inflammation and Vaccines of IDIS, which has led Galicia to “Be a worldwide reference in immunization”. In this sense, he referred to the presentation of the results of the Galflu essaywhich proved the effectiveness of the high -loading flu vaccine against the standard in people of 65 to 79 yearsreducing flu hospitalization by almost 32%.
Gómez Caamaño concluded remembering that Galicia was “Pioneer” in 2023 in the vaccination of babies in front of the respiratory virus, responsible for most hospital admissions in the first months of life.
